Management of patients with cardiac stents undergoing noncardiac surgery

Area of Science:

• Cardiology
• Interventional Cardiology
• Perioperative Medicine

Background:

• Coronary stenting is a common procedure, with millions performed annually.
• A significant percentage of patients require non-cardiac surgery within a year post-stenting.
• Concerns exist regarding surgery-induced hypercoagulability and its impact on stent thrombosis and cardiac outcomes.

Purpose of the Study:

• To evaluate the cardiac outcomes of patients undergoing non-cardiac surgery after coronary stenting.
• To investigate the role of antiplatelet therapy interruption in perioperative adverse events.
• To assess the efficacy of prophylactic coronary revascularization in high-risk patients.

Main Methods:

• Review of existing literature on perioperative outcomes after coronary stenting.
• Analysis of major adverse cardiac events (MACE) in relation to timing of surgery and antiplatelet therapy.
• Evaluation of outcomes for patients who underwent prophylactic coronary revascularization prior to non-cardiac surgery.

Main Results:

• Early non-cardiac surgery post-stenting is linked to a higher risk of MACE, primarily in-stent thrombosis.
• Discontinuation of antiplatelet therapy perioperatively significantly increases adverse cardiac events.
• Prophylactic coronary revascularization did not improve outcomes in high-risk, stable patients.

Conclusions:

• Non-cardiac surgery performed early after coronary stenting elevates postoperative cardiac event risk.
• Perioperative antiplatelet therapy management is critical in mitigating these risks.
• Preoperative revascularization is not beneficial for stable, high-risk patients undergoing non-cardiac surgery.